vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $31.4M, roughly 1.5× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -4.8%, a 41.1% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $54.6M). Over the past eight quarters, Ponce Financial Group, Inc.'s revenue compounded faster (23.7% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
IRWD vs PDLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $31.4M |
| Net Profit | $-2.3M | $10.1M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 43.6% |
| Net Margin | -4.8% | 36.3% |
| Revenue YoY | -47.3% | 37.6% |
| Net Profit YoY | -200.9% | 245.6% |
| EPS (diluted) | $0.01 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $31.4M | ||
| Q3 25 | $122.1M | $26.7M | ||
| Q2 25 | $85.2M | $26.5M | ||
| Q1 25 | $41.1M | $24.6M | ||
| Q4 24 | $90.5M | $22.8M | ||
| Q3 24 | $91.6M | $20.2M | ||
| Q2 24 | $94.4M | $20.2M | ||
| Q1 24 | $74.9M | $20.5M |
| Q4 25 | $-2.3M | $10.1M | ||
| Q3 25 | $40.1M | $6.5M | ||
| Q2 25 | $23.6M | $6.1M | ||
| Q1 25 | $-37.4M | $6.0M | ||
| Q4 24 | $2.3M | $2.9M | ||
| Q3 24 | $3.6M | $2.4M | ||
| Q2 24 | $-860.0K | $3.2M | ||
| Q1 24 | $-4.2M | $2.4M |
| Q4 25 | 14.3% | 43.6% | ||
| Q3 25 | 61.8% | 32.8% | ||
| Q2 25 | 53.2% | 30.2% | ||
| Q1 25 | -70.7% | 32.5% | ||
| Q4 24 | 34.8% | 19.6% | ||
| Q3 24 | 28.0% | 15.2% | ||
| Q2 24 | 26.5% | 21.8% | ||
| Q1 24 | 14.7% | 18.3% |
| Q4 25 | -4.8% | 36.3% | ||
| Q3 25 | 32.8% | 24.3% | ||
| Q2 25 | 27.7% | 23.0% | ||
| Q1 25 | -90.9% | 24.2% | ||
| Q4 24 | 2.5% | 14.1% | ||
| Q3 24 | 4.0% | 12.1% | ||
| Q2 24 | -0.9% | 15.8% | ||
| Q1 24 | -5.6% | 11.8% |
| Q4 25 | $0.01 | $0.43 | ||
| Q3 25 | $0.23 | $0.27 | ||
| Q2 25 | $0.14 | $0.25 | ||
| Q1 25 | $-0.23 | $0.25 | ||
| Q4 24 | $0.03 | $0.11 | ||
| Q3 24 | $0.02 | $0.10 | ||
| Q2 24 | $-0.01 | $0.14 | ||
| Q1 24 | $-0.03 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $126.2M |
| Total DebtLower is stronger | — | $596.1M |
| Stockholders' EquityBook value | $-261.8M | $541.5M |
| Total Assets | $396.9M | $3.2B |
| Debt / EquityLower = less leverage | — | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $126.2M | ||
| Q3 25 | $140.4M | $146.6M | ||
| Q2 25 | $92.9M | $126.6M | ||
| Q1 25 | $108.5M | $129.9M | ||
| Q4 24 | $88.6M | $139.8M | ||
| Q3 24 | $88.2M | $155.8M | ||
| Q2 24 | $105.5M | $103.2M | ||
| Q1 24 | $121.5M | $134.7M |
| Q4 25 | — | $596.1M | ||
| Q3 25 | $199.5M | $521.1M | ||
| Q2 25 | $199.3M | $536.1M | ||
| Q1 25 | $199.2M | $521.1M | ||
| Q4 24 | $199.0M | $596.1M | ||
| Q3 24 | $198.8M | $580.4M | ||
| Q2 24 | $198.6M | $680.4M | ||
| Q1 24 | $398.3M | $680.4M |
| Q4 25 | $-261.8M | $541.5M | ||
| Q3 25 | $-264.2M | $529.8M | ||
| Q2 25 | $-308.2M | $521.1M | ||
| Q1 25 | $-334.1M | $513.9M | ||
| Q4 24 | $-301.3M | $505.5M | ||
| Q3 24 | $-311.3M | $504.6M | ||
| Q2 24 | $-321.7M | $497.7M | ||
| Q1 24 | $-330.5M | $493.7M |
| Q4 25 | $396.9M | $3.2B | ||
| Q3 25 | $396.1M | $3.2B | ||
| Q2 25 | $342.9M | $3.2B | ||
| Q1 25 | $327.2M | $3.1B | ||
| Q4 24 | $350.9M | $3.0B | ||
| Q3 24 | $389.5M | $3.0B | ||
| Q2 24 | $395.6M | $2.8B | ||
| Q1 24 | $438.8M | $2.8B |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $55.6M |
| Free Cash FlowOCF − Capex | $74.6M | $54.6M |
| FCF MarginFCF / Revenue | 156.3% | 173.9% |
| Capex IntensityCapex / Revenue | 0.0% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $55.6M | ||
| Q3 25 | $47.6M | $1.4M | ||
| Q2 25 | $-15.1M | $6.2M | ||
| Q1 25 | $20.0M | $13.1M | ||
| Q4 24 | $15.2M | $7.2M | ||
| Q3 24 | $9.9M | $-14.6M | ||
| Q2 24 | $33.5M | $-2.6M | ||
| Q1 24 | $45.0M | $1.5M |
| Q4 25 | $74.6M | $54.6M | ||
| Q3 25 | $47.6M | $786.0K | ||
| Q2 25 | $-15.1M | $5.9M | ||
| Q1 25 | $19.9M | $12.9M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $9.9M | $-15.0M | ||
| Q2 24 | $33.4M | $-2.6M | ||
| Q1 24 | $44.9M | $-315.0K |
| Q4 25 | 156.3% | 173.9% | ||
| Q3 25 | 39.0% | 2.9% | ||
| Q2 25 | -17.7% | 22.4% | ||
| Q1 25 | 48.4% | 52.6% | ||
| Q4 24 | — | 19.7% | ||
| Q3 24 | 10.8% | -74.1% | ||
| Q2 24 | 35.4% | -13.0% | ||
| Q1 24 | 60.0% | -1.5% |
| Q4 25 | 0.0% | 3.1% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 11.9% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.1% | 0.3% | ||
| Q1 24 | 0.1% | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | 1.19× | 0.21× | ||
| Q2 25 | -0.64× | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | 6.74× | 2.46× | ||
| Q3 24 | 2.71× | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
